Scripps Physician Discusses Newly Approved Drug to Treat Influenza

Primary care doctor focuses on flu protection in media interviews

Dr. Erik Hogen discussing flu trends in San Diego with KUSI host Lauren Phinney.

KUSI host Lauren Phinney and Dr. Erik Hogen, Primary Care, Scripps Clinic, discussing flu season.

Primary care doctor focuses on flu protection in media interviews

Erik Hogen, MD, a pediatrician at Scripps Clinic Rancho Bernardo, recently discussed the newly FDA-approved antiviral drug Xofluza and how it helps to reduce symptoms of the flu and shorten its duration during an interview with KUSI.


Dr. Hogen explained flu symptoms and how quickly they can arise in otherwise healthy people in an article that appeared in The San Diego Union-Tribune.


National Influenza Vaccination Week this year is scheduled for December 2-8. The national awareness campaign highlights the importance of continuing flu vaccination through the holiday season and beyond.


Read the story in The San Diego Union-Tribune: Newly approved drug Xofluz adds to flu fighting arsenal


Watch the segment on KUSI: FDA approves new flu drug called Xofluza.

Media Contact

Keith Darce
858-678-7121
darce.keith@scrippshealth.org
Follow me: @KeithDarce